Molecular pathogenesis of malignant gliomas.
作者： B. K. Ahmed Rasheed , Rodney N. Wiltshire , Sandra H. Bigner , Darell D. Bigner
DOI: 10.1097/00001622-199905000-00004
关键词:
摘要: De novo glioblastomas develop in older patients without prior clinical history of less malignant tumors. Progressive are common among younger and arise through progression from lower-grade astrocytomas. CDKN2A deletions, PTEN alterations, EGFR amplification more preval
sci-hub.st 参考文章(34)
Guido Reifenberger, Ghazaleh Tabatabai, Marietta Wolter, J. M. J. Ludwig Cobbers, V. Peter Collins, Peter Lichter, Ruthild G. Weber, Jan Boström, Mutation of the PTEN (MMAC1) Tumor Suppressor Gene in a Subset of Glioblastomas but not in Meningiomas with Loss of Chromosome Arm 10q Cancer Research. ,vol. 58, pp. 29- 33 ,(1998)
Paul Cairns, David Sidransky, Janusz Puc, Jeffrey N. Bruce, Steven I. Wang, Ramon Parsons, Jing Li, Somatic mutations of PTEN in glioblastoma multiforme. Cancer Research. ,vol. 57, pp. 4183- 4186 ,(1997)
Wojciech Biernat, Yasuo Tohma, Yasuhiro Yonekawa, Paul Kleihues, H. Ohgaki, Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas Acta Neuropathologica. ,vol. 94, pp. 303- 309 ,(1997) , 10.1007/S004010050711
Ming Mai, Haojie Huang, Christopher Reed, Chiping Qian, Justin S. Smith, Benjamin Alderete, Robert Jenkins, David I. Smith, Wanguo Liu, Genomic Organization and Mutation Analysis ofp73in Oligodendrogliomas with Chromosome 1 p-Arm Deletions Genomics. ,vol. 51, pp. 359- 363 ,(1998) , 10.1006/GENO.1998.5387
Theo J. M. Hulsebos, Niels T. Oskam, Dirk Troost, Sieger Leenstra, Engelien H. Bijleveld, Dynamics of genetic alterations associated with glioma recurrence Genes, Chromosomes and Cancer. ,vol. 23, pp. 153- 158 ,(1998) , 10.1002/(SICI)1098-2264(199810)23:2<153::AID-GCC8>3.0.CO;2-1
D Fults, C A Pedone, G E Thompson, C M Uchiyama, K L Gumpper, D Iliev, V L Vinson, S V Tavtigian, W L Perry, Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme. International Journal of Oncology. ,vol. 12, pp. 905- 910 ,(1998) , 10.3892/IJO.12.4.905
J. Gregory Cairncross, Keisuke Ueki, Magdelena C. Zlatescu, David K. Lisle, Dianne M. Finkelstein, Robert R. Hammond, Jonathan S. Silver, Paul C. Stark, David R. Macdonald, Yasushi Ino, David A. Ramsay, David N. Louis, Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas Journal of the National Cancer Institute. ,vol. 90, pp. 1473- 1479 ,(1998) , 10.1093/JNCI/90.19.1473
R P T Somerville, Y Shoshan, C Eng, G Barnett, D Miller, J K Cowell, Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression. Oncogene. ,vol. 17, pp. 1755- 1757 ,(1998) , 10.1038/SJ.ONC.1202066
Greg Eley, Lori Frederick, Xiao-Yang Wang, David I. Smith, C. David James, 3′ End structure and rearrangements ofEGFR in glioblastomas Genes, Chromosomes and Cancer. ,vol. 23, pp. 248- 254 ,(1998) , 10.1002/(SICI)1098-2264(199811)23:3<248::AID-GCC7>3.0.CO;2-1
Elizabeth W. Newcomb, Henry Cohen, Suzanne R. Lee, Sandhya K. Bhalla, Joanna Bloom, Roberta L. Hayes, Douglas C. Miller, Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathology. ,vol. 8, pp. 655- 667 ,(1998) , 10.1111/J.1750-3639.1998.TB00191.X